“The Mount Sinai Recanati/Miller Transplantation Institute is currently participating in several Hepatitis B and Hepatitis C clinical trials. For more information about these clinical research opportunities, you may contact the Clinical Research Director by phone at 212-241-0255 or email at TXresearch@mountsinai.org”
Last Updated on January 25, 2020 by HepFree NYC
The NYC Hep C Task Force & Hep B Coalition created a workgroup in 2013 to address hepatitis in the Caribbean communities of NYC.
NYS Medicaid Removes Hep C Experienced Provider Requirement from Prior Authorization Criteria
The NYC Health Department today released the City's first-ever plan for reducing illness and death from the hepatitis C virus (HCV), a disease that now accounts for more annual deaths nationwide than HIV/AIDS
On Feb 26th, 2015, the NYS Drug Utilization Review Board (DURB) voted unanimously to move Viekira Pak to preferred status for NYS Medicaid Fee-for-service members, and to remove restrictions based on disease prognosis and severity from the current clinical criteria for Viekira Pa...
Study shows that two out of five Bronx residents who test positive for hepatitis C are undiagnosed. The Health Department’s Viral Hepatitis Program offers free resources to support health care providers in hepatitis B and C screening and care.
Help us launch the Hep Free NYC LGBTQ Initiative by completing a short survey here. This survey allows hepatitis and LGBTQ organizations give advice and recommendations on how we can create an impactful and successful initiative.
Learn about FREE VIRAL HEPATITIS TRAINING opportunities throughout New York State.
SAVE THE DATE! Wednesday, July 25th is the 6th Annual National African American Hepatitis C Action Day (NAAHCAD). This day provides an opportunity to promote Hepatitis C prevention, testing, and treatment messages to public health partners and the black community. NAAHCAD also pr...
